Zobrazeno 1 - 10 of 27 pro vyhledávání: '"Everett, CC"'
2
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy
Autor: Fisher, BA, Everett, CC, Rout, J, O'Dwyer, JL, Emery, P, Pitzalis, C, Ng, W-F, Carr, A, Pease, CT, Price, EJ, Sutcliffe, N, Makdissi, J, Tappuni, AR, Gendi, NST, Hall, FC, Ruddock, SP, Fernandez, C, Hulme, CT, Davies, KA, Edwards, CJ, Lanyon, PC, Moots, RJ, Roussou, E, Richards, A, Sharples, LD, Bombardieri, M, Bowman, SJ
Publikováno v: Annals of the Rheumatic Diseases
Objectives To compare the effects of rituximab versus placebo on salivary gland ultrasound (SGUS) in primary Sjögren’s syndrome (PSS) in a multicentre, multiobserver phase III trial substudy.\ud \ud \ud \ud Methods Subjects consenting to SGUS were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d9f4a79990416b5a98fb355d2854f32c
Zobrazit plný text záznamu
4
Randomized Controlled Trial of Rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's Syndrome
Autor: Bowman, SJ, Everett, CC, O'Dwyer, JL, Emery, P, Pitzalis, C, Ng, WF, Pease, CT, Price, EJ, Sutcliffe, N, St Gendi, N, Hall, FC, Ruddock, SP, Fernandez, C, Reynolds, C, Hulme, CT, Davies, KA, Edwards, CJ, Lanyon, PC, Moots, RJ, Roussou, E, Giles, IP, Sharples, LD, Bombardieri, M
We investigated whether rituximab, an anti-B-cell therapy, improved symptoms of fatigue and oral dryness in patients with Primary Sjögren's Syndrome (PSS). : Multicentre, randomised, double-blind, parallel-group placebo-controlled trial, including H
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a46344a98eeb2524dccbb59bf2b06071
Zobrazit plný text záznamu
6
Akademický článek
Theoretically-informed vs standard cover letter to improve participant response to mailed questionnaire: results of an embedded randomised retention trial.
Autor: Everett CC; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. colin.everett@manchester.ac.uk., Brown ST; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Dennett JL; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Collier H; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Davies CL; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Game F; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, Derbyshire, UK., Nelson EA; Glasgow Caledonian University, Glasgow, Scotland, UK.
Publikováno v: Trials [Trials] 2024 Nov 14; Vol. 25 (1), pp. 763. Date of Electronic Publication: 2024 Nov 14.
Zobrazit plný text záznamu
7
Akademický článek
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2.
Autor: Everett CC; School of Medicine, University of Leeds, Leeds, UK., Berry C; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., McCann GP; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Fernandez C; School of Medicine, University of Leeds, Leeds, UK., Reynolds C; School of Medicine, University of Leeds, Leeds, UK., Bucciarelli-Ducci C; Department of Cardiology, Harefield Hospital, Harefield, UK., Dall'Armellina E; School of Medicine, University of Leeds, Leeds, UK.; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Prasad A; Cardiovascular Diseases, Mayo Clinic Minnesota, Rochester, Minnesota, USA., Foley JR; School of Medicine, University of Leeds, Leeds, UK.; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Mangion K; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Bijsterveld P; School of Medicine, University of Leeds, Leeds, UK., Brown J; School of Medicine, University of Leeds, Leeds, UK., Stocken D; School of Medicine, University of Leeds, Leeds, UK., Walker S; Centre for Health Economics, University of York, York, UK., Sculpher M; Centre for Health Economics, University of York, York, UK., Plein S; School of Medicine, University of Leeds, Leeds, UK.; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Greenwood JP; School of Medicine, University of Leeds, Leeds, UK j.greenwood@leeds.ac.uk.; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Publikováno v: Open heart [Open Heart] 2023 May; Vol. 10 (1).
Zobrazit plný text záznamu
8
Akademický článek
Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
Autor: Ajjan RA; Clinical Population and Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K., Heller SR; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, U.K., Everett CC; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, U.K., Vargas-Palacios A; Academic Unit of Health Economics, University of Leeds, Leeds, U.K., Higham R; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, U.K., Sharples L; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, U.K., Gorog DA; School of Life and Medical Science, University of Hertfordshire, Hertfordshire, U.K.; National Heart and Lung Institute, Imperial College London, London, U.K., Rogers A; Patient representative., Reynolds C; Clinical Population and Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K., Fernandez C; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, U.K., Rodrigues P; Academic Unit of Health Economics, University of Leeds, Leeds, U.K., Sathyapalan T; Academic Diabetes, Endocrinology and Metabolism, Allam Diabetes Centre, Hull York Medical School, University of Hull, Hull, U.K., Storey RF; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, U.K., Stocken DD; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, U.K.
Publikováno v: Diabetes care [Diabetes Care] 2023 Feb 01; Vol. 46 (2), pp. 441-449.
Zobrazit plný text záznamu
9
Akademický článek
Visualising harms in publications of randomised controlled trials: consensus and recommendations.
Autor: Phillips R; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK r.phillips@imperial.ac.uk.; Pragmatic Clinical Trials Unit, Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Cro S; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK., Wheeler G; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK., Bond S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Morris TP; MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, UK., Creanor S; Exeter Clinical Trials Unit, University of Exeter, Exeter, UK., Hewitt C; York Trials Unit, University of York, York, UK., Love S; MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, UK., Lopes A; CRUK Cancer Trials Centre, University College London, London, UK., Schlackow I; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Gamble C; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK., MacLennan G; Centre for Health Care Randomised Trials, University of Aberdeen, Aberdeen, UK., Habron C; Roche Products, Welwyn Garden City, UK., Gordon AC; Division of Anaesthetics, Pain Medicine, and Intensive Care, Department of Surgery and Cancer, Imperial College London and Imperial College Healthcare NHS Trust, London, UK., Vergis N; Imperial College London and Imperial NHS Trust, London, UK., Li T; Department of Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Qureshi R; Department of Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Everett CC; Clinical Trials Research Unit, Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK., Holmes J; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Kirkham A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Peckitt C; Royal Marsden Clinical Trials Unit, Royal Marsden NHS Foundation Trust, London, UK., Pirrie S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Ahmed N; Comprehensive Clinical Trials Unit, University College London, London, UK., Collett L; Bristol Trials Centre, University of Bristol, Bristol, UK., Cornelius V; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK.
Publikováno v: BMJ (Clinical research ed.) [BMJ] 2022 May 16; Vol. 377, pp. e068983. Date of Electronic Publication: 2022 May 16.
Zobrazit plný text záznamu
10
Akademický článek
A roadmap to using randomization in clinical trials.
Autor: Berger VW; National Institutes of Health, Bethesda, MD, USA., Bour LJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Carter K; Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA., Chipman JJ; Population Health Sciences, University of Utah School of Medicine, Salt Lake City UT, USA.; Cancer Biostatistics, University of Utah Huntsman Cancer Institute, Salt Lake City UT, USA., Everett CC; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Heussen N; RWTH Aachen University, Aachen, Germany.; Medical School, Sigmund Freud University, Vienna, Austria., Hewitt C; York Trials Unit, Department of Health Sciences, University of York, York, UK., Hilgers RD; RWTH Aachen University, Aachen, Germany., Luo YA; Food and Drug Administration, Silver Spring, MD, USA., Renteria J; Open University of Catalonia (UOC) and the University of Barcelona (UB), Barcelona, Spain.; Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD, USA., Ryeznik Y; BioPharma Early Biometrics & Statistical Innovations, Data Science & AI, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden., Sverdlov O; Early Development Analytics, Novartis Pharmaceuticals Corporation, NJ, East Hanover, USA. alex.sverdlov@novartis.com., Uschner D; Biostatistics Center & Department of Biostatistics and Bioinformatics, George Washington University, DC, Washington, USA.
Publikováno v: BMC medical research methodology [BMC Med Res Methodol] 2021 Aug 16; Vol. 21 (1), pp. 168. Date of Electronic Publication: 2021 Aug 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje